Stock UniverseDerived research view · source repositories remain read-only

Verastem, Inc. (VSTM)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Watch
Selection Score
30.28
Global Rank
1929
Market Cap
441.48M
Latest Close
3.71
RS Composite
-53.69% · G#3296

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-38.27%
3M
-41.85%
6M
-63.12%
1Y
-39.87%
3Y
-69.69%
5Y
-92.01%
10Y
-79.25%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 3.03M · 30-day average: 2.38M · Max drawdown over stored range: -98.16%

Research Snapshot

Relative Strength vs SPX

RS Composite-53.69%
20D RS-35.09%
60D RS-49.04%
120D RS-67.65%
Global RS Rank3296 · 1.76% percentile
Watch+Speculative RS Rank2044 · 2.53% percentile
Group ScopeWatch+Speculative
Primary RS Rank437 · 4.59% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank282 / 701
Primary Percentile59.91
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2026-03-312026-05-0749.59Mn/a-170.85M-193.96M-2.35-260.96Mn/an/a82Mn/a-3.45%-3.91%-5.26%n/a181.68Mn/a

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2026-03-31$-2.35-1.6x$0.606.2xn/an/a$-3.16-1.2x

Shares Diluted: 82M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue88.5162.0532.59601030.914
Revenue Growth (YoY)407.081%-97.681%26.449%2800%2800%209.14%
Gross Profit55.5642.0532.596010
Operating Income-44.76-61.409-72.937-92.084-114.956
Free Cash Flow-33.539-53.698-63.673-86.46-104.799-137.509
Free Cash Flow Per Share-2.625-3.694-3.946-3.92-2.934-1.983999192024124
EPS (Diluted) GAAP-5.300412-4.89852-4.5738-3.961503-3.657967
EPS Growth
EPS Non-GAAP
Gross Margin62.773%100%100%2800%100%82.8621%
Operating Margin-50.567%-2991.184%-2809.592%2800%-1149.56%-550.3299%
Profit Margin-76.513%-3468.095%-2843.297%2800%-1306.37%-677.5927%
Free Cash Flow Margin-37.89%-2615.587%-2452.735%2800%-1047.99%-444.8114%
Shares Outstanding (Diluted)12.777514.53516.13822.05435.71369.309
Shares Change (YoY)105.597%13.755%11.029%36.659%61.934%94.072%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2026 Q12026-05-0718.67Mn/a-44.90M-2.40%-36.59M-1.96%-0.4699.15M181.68Mn/aprocessed
2025 Q42026-03-0417.54Mn/a-41.48M-2.37%-32.92M-1.88%-0.3983.55M204.99M40.72Mprocessed
2025 Q32025-11-0411.24Mn/a-40.72M-3.62%-98.52M-8.76%-1.3573.16M137.71M40.72Mprocessed
2025 Q22025-08-072.14Mn/a-43.76M-20.48%-25.93M-12.14%-0.6274.04M164.32M40.72Mprocessed
2025 Q12025-05-13n/an/a-44.17Mn/a-52.10Mn/a-0.9654.17M117.57M40.72Mprocessed
2024 Q42025-03-200.00n/a-31.59Mn/a-64.55Mn/a-1.3248.80M88.82M40.72Mprocessed
2024 Q32024-11-0610.00Mn/a-37.03M-3.70%-23.97M-2.40%-0.6040.26M113.17M40.52Mprocessed
2024 Q12024-08-0810.00Mn/a-18.28M-1.83%-8.26M-82.56%-0.31n/a83.37M40.32Mprocessed
2024 Q12024-05-09n/an/a-28.06Mn/a-33.86Mn/a-0.08200.68M81.32M40.12Mprocessed
2023 Q42024-03-140.00n/a-31.14Mn/a-27.37Mn/an/an/a77.91M40.09Mprocessed
2023 Q32023-11-082.60Mn/a-21.31M-8.21%-20.00M-7.71%-0.08200.68M94.99M39.91Mprocessed
2023 Q22023-08-082.60Mn/a-20.29M-7.82%-24.28M-9.35%-0.08200.68M183.09M39.74Mprocessed
2023 Q12023-05-092.60Mn/a-19.34M-7.45%-15.71M-6.05%-0.08200.68M97.26M39.57Mprocessed
2022 Q42023-03-140.00n/a-16.85Mn/a-16.81Mn/a0.03-569.22M74.93M24.53Mprocessed
2022 Q32022-11-032.00Kn/a-17.71M-8854.50%-18.09M-9045.00%-0.09197.15M78.17M24.40Mprocessed
2022 Q22022-08-08500.00Kn/a-21.40M-42.80%-21.95M-43.90%-0.12186.46M63.95M24.28Mprocessed
2022 Q12022-05-092.60Mn/a-16.98M-6.54%-16.96M-6.53%-0.09186.26M46.69M24.16Mprocessed
2021 Q42022-03-28545.00Kn/a-16.51M-30.30%-16.48M-30.24%-0.09174.05M21.25Mn/aprocessed
2021 Q32021-11-042.00Kn/a-14.85M-7423.00%-22.79M-11393.00%-0.13179.86M24.31Mn/aprocessed
2021 Q22021-08-02500.00Kn/a-15.94M-31.89%-16.90M-33.80%n/an/a24.97Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.